DalsnaFinance

Core Scientific Inc $CORZ

Information Technology

Russell 2000 Delaware
Create a scorecard
$13.79
+0.06 (+0.44%)
As of Oct 20, 2026, 6:42 PM EDT · cached
Price history
Loading chart…
Today's analyst average Analyst average over timeIndividual analyst targets Analyst history starts Jul 29, 2026, the first target we tracked for CORZ.

Core Scientific Inc (CORZ) is trading up at $13.79 (+0.44%), as of the latest quote. It is a Russell 2000 constituent in the Information Technology sector.

Analyst price targets on CORZ

Current price targets from 2 firms average $34, ranging from $33 to $35 — 147% above the current $13.8. Each is tracked to its date and scored the same way a member's call is.

Targets published by research firms, extracted from the news, checked against independent reporting, and linked to their source. Where a firm did not state a horizon the target is tracked as 12 months, the industry convention; the rows where the firm set its own horizon are marked. Reported here as facts about what was published — not recommendations from Dalsna Finance, and no firm listed is affiliated with this site.

Core Scientific Inc revenue & net income history (FY2020–FY2025)

RevenueNet incomeNet margin (right axis, %)
$640.3M−$753.0M−$2.15BFY2020 revenue: $60.3MFY2020 net income: −$12.2M · Net margin −20.2%'20FY2021 revenue: $544.5MFY2021 net income: $47.3M · Net margin 8.7%'21FY2022 revenue: $640.3MFY2022 net income: −$2.15B · Net margin −335.2%'22FY2023 revenue: $502.4MFY2023 net income: −$246.5M · Net margin −49.1%'23FY2024 revenue: $510.7MFY2024 net income: −$1.44B · Net margin −281.6%'24FY2025 revenue: $319.0MFY2025 net income: −$288.6M · Net margin −90.5%'25−75%−50%−25%0%25%FY2020 net margin: −20.2%FY2021 net margin: 8.7%FY2022 net margin: −335.2% (off the scale, which stops at −83.8%)FY2023 net margin: −49.1%FY2024 net margin: −281.6% (off the scale, which stops at −83.8%)FY2025 net margin: −90.5% (off the scale, which stops at −83.8%)
Core Scientific Inc annual financial statements
FY2020Dec 2020FY2021Dec 2021FY2022Dec 2022FY2023Dec 2023FY2024Dec 2024FY2025Dec 2025
Income statement
Revenue$60.3M$544.5M$640.3M$502.4M$510.7M$319.0M
Growth (year over year)—+802.7%+17.6%−21.5%+1.6%−37.5%
Gross profit$9.39M$238.9M$8.40M$123.5M$121.1M$37.9M
Gross margin15.6%43.9%1.3%24.6%23.7%11.9%
Operating income−$6.33M$131.5M−$2.11B$8.96M−$142.1M−$245.6M
Operating margin−10.5%24.2%−329.5%1.8%−27.8%−77.0%
Net income−$12.2M$47.3M−$2.15B−$246.5M−$1.44B−$288.6M
Net margin−20.2%8.7%−335.2%−49.1%−281.6%−90.5%
EPS (diluted)−$0.14$0.20−$6.30−$0.65−$4.87−$0.88
Balance sheet
Cash and equivalents$8.72M$117.9M$15.9M$50.4M$836.2M$311.4M
Total assets$15.0K$2.44B$807.7M$712.2M$1.48B$2.35B
Total liabilities$400$1.05B$1.22B$1.31B$2.42B$3.31B
Long-term debt—————$1.06B
Shareholders' equity—$1.34B−$409.3M−$596.9M−$943.0M−$962.7M
Cash flow
Operating cash flow−$23.8M−$56.7M$205.2M$65.1M$42.9M$278.3M
Capital expenditure$0$0$384.0M$16.2M$95.0M$729.0M
Free cash flow−$23.8M−$56.7M−$178.8M$49.0M−$52.1M−$450.8M
Share buybacks——$31.6M$0$0—

From Core Scientific Inc's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. Net margin is our own calculation from those reported figures (net income ÷ revenue); it is left blank where revenue is zero or missing. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →

About Core Scientific Inc

Headquarters
Dover, Delaware From SEC filings, Oct 2026

Recent News (20)

More Information Technology stocks

Browse all companies →